Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumateperone for MDD and Early Life Trauma
NCT07369115Phase 4Not yet recruiting
- Sponsor
- University of Texas at Austin
- Start
- Feb 2026
- Primary completion
- Jan 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lumateperone in major depressive disorder (MDD), sponsored by University of Texas at Austin. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
lumateperone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07369115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07369115.